Related Experiment Video

Updated: Jun 21, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Vascular cognitive impairment: dementia biology and translational animal models

Frank C Barone1, Daniel M Rosenbaum, Jin Zhou

  • 1SUNY Downstate Medical Center, School of Medicine, Department of Neurology, 450 Clarkson Avenue, Box 1213, Brooklyn, NY 11225, USA. frank.barone@downstate.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|July 7, 2009
PubMed

Insights

Vascular cognitive impairment (VCI), linked to cardiovascular disease, is a major dementia cause. Animal models of cerebrovascular insufficiency are crucial for understanding VCI and Alzheimer's disease (AD) progression, aiding biomarker discovery and therapeutic development.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Dementia Studies

Background:

  • Vascular cognitive impairment (VCI) is the second most common dementia, stemming from cerebrovascular disease (CVD).
  • VCI shares risk factors with Alzheimer's disease (AD) and may influence AD progression, and vice versa.
  • Understanding CVD mechanisms in cognitive decline necessitates translational animal models.

Purpose of the Study:

  • To review animal models of cerebrovascular insufficiency (chronic hypoperfusion, hypertension) that induce experimental VCI.
  • To examine the relevance of these models to human VCI and AD.
  • To highlight the potential of these models for discovering diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Review of existing literature on animal models simulating chronic hypoperfusion and hypertension.
  • Analysis of how these models replicate aspects of human VCI and AD.
  • Evaluation of the utility of these models for translational research.

Main Results:

  • Animal models of chronic hypoperfusion and hypertension effectively produce experimental VCI.
  • These models offer insights into the relationship between CVD, VCI, and AD.
  • The models provide a platform for investigating disease mechanisms.

Conclusions:

  • Translational animal models are essential for advancing VCI research.
  • These models can facilitate the identification of novel biomarkers and therapeutic targets for VCI and potentially AD.
  • Early identification and intervention strategies for VCI can be developed using insights from these models.

More Related Videos

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...